Orofacial Pain in Multiple Sclerosis
NCT06021561 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2024-04-09
Summary
Although the orofacial pain is not typical symptom of multiple sclerosis, more than 50% of the patients experience some kind of pain. Acute pain usually in form of trigeminal neuralgia, that occurred in 2-3% of patients with multiple sclerosis. Chronic pain occurred in 40-50% of patients and most common forms are headache. Aim of this study is to investigate prevalence and evaluate the form of orofacial pain in patients with multiple sclerosis treated in General hospital Varaždin in period from 01.01. 2017. to 31.12.2022. Results of this investigation will determine better understanding orofacial pain , treatment and impact on everyday life.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Diagnosis of pain
Pain will be investigated - type, origin, level
Sponsors & Collaborators
-
Varazdin General Hospital
lead OTHER
Principal Investigators
-
Monika Kocman Panic, MD · Varazdin General Hospital, Varazdin, Croatia
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-04
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- Croatia
Study Locations
More Related Trials
-
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
NCT02792231 ·Status: COMPLETED ·Phase: PHASE3
-
Self Help for Fatigue in Multiple Sclerosis
NCT01532037 ·Status: COMPLETED ·Phase: NA
-
A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis
NCT02576717 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Patients With Multiple Sclerosis (MS)
NCT00001156 ·Status: COMPLETED
-
The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis
NCT00917839 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of 4-aminopyridine on Cognitive Performance and Motor Function of Patients With Multiple Sclerosis
NCT02280096 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Oral Fampridine-SR in Multiple Sclerosis
NCT00127530 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
NCT05156281 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Ocrelizumab Effects on Physiological and Cognitive Changes in Multiple Sclerosis
NCT03025269 ·Status: COMPLETED
-
The Efficacy of Pulse Therapy in Acute Relapse in Multiple Sclerosis Patients:
NCT06280131 ·Status: NOT_YET_RECRUITING
-
A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS
NCT03290131 ·Status: COMPLETED ·Phase: PHASE3
-
Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis
NCT01517282 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
BrainAgeMS - a Comparative Study of Brain Aging in Healthy and Patients With Multiple Sclerosis
NCT06221631 ·Status: RECRUITING
-
Electrical Stimulations on Pain, Functional Capacity and Quality of Life in Multiple Sclerosis
NCT05110586 ·Status: COMPLETED ·Phase: NA
-
Cortical Inhibition in Patients With Multiple Sclerosis
NCT07128160 ·Status: NOT_YET_RECRUITING
-
Description of Adherence to the Main Preventive Health Campaigns of Persons With Multiple Sclerosis
NCT04930380 ·Status: UNKNOWN
-
Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS
NCT02797015 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple Sclerosis
NCT04261790 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Relapse Presence in Multiple Sclerosis
NCT05218317 ·Status: COMPLETED
-
Fatigue in Multiple Sclerosis and Its Relationship to Inflammatory and Neurodegenerative Markers of the Disease
NCT07025122 ·Status: ENROLLING_BY_INVITATION
-
Symptom Burden in Patients Treated With Ocrelizumab for Multiple Sclerosis
NCT04855617 ·Status: COMPLETED
-
Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients
NCT05596526 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS)
NCT05119569 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Understanding Magnetic Resonance Imaging in Multiple Sclerosis
NCT03872583 ·Status: COMPLETED ·Phase: NA
-
Adverse Childhood Experiences in Patients With MS: Impact on Quality of Life and on Coping Strategies Towards the Disease and Its Treatment
NCT06718920 ·Status: RECRUITING